Amgen

News

Novartis CAR-T safety in FDA spotlight

FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to focus on safety concerns in the decisive meeting.

News

A sad young woman is sitting in her kitchen with a headache

Alder shares slump despite migraine success

Investors concerned over strong placebo effect

News

Novartis files migraine drug with EMA

Erenumab could be first new treatment in a decade.

News

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Companies awaiting CV outcomes trial, and court decision in patent case

News

Teva on track to file migraine blockbuster

Phase 3 success for fremanezumab.

News

abstract shapes, bone structure, 3d render, bone

Safety restrictions spell the end for Servier osteoporosis d...

Sales of Protelos hit by safety restrictions.

Novartis CAR-T safety in FDA spotlight

Alder shares slump despite migraine success

Novartis files migraine drug with EMA

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien...

Teva on track to file migraine blockbuster

Safety restrictions spell the end for Servier osteoporosis d...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Amgen

Editor's Picks